Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

REGENERON PHARMACEUTICALS, INC

Filed by REGENERON PHARMACEUTICALS, INC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-06 06:26:26 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 21, 2026
Income
Not reported
Expenses
$590,000.00
Filing UUID
28bf8ef6-d70b-409d-93a8-b17bd3417bcd
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

CPT · Copyright/Patent/Trademark

Intellectual property legislation related to biopharmaceutical manufacturers.

TRD · Trade (domestic/foreign)

Trade and tariff issues related to corporations; outbound investment restrictions related to biopharmaceutical manufacturers.

TAX · Taxation/Internal Revenue Code

Tax and inflation issues related to corporations.

HCR · Health Issues

Privacy legislation related to biopharmaceutical manufacturers; Food and Drug Administration and manufacturing issues related to biopharmaceutical manufacturers; National security issues related to biopharmaceutical manufacturers; Public-private contracts for innovation in the biopharmaceutical space; Biosimilar issues related to biopharmaceutical manufacturers.

MMM · Medicare/Medicaid

Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.